Quinacrine sensitizes hepatocellular carcinoma cells to TRAIL and chemotherapeutic agents.
Wang W, Gallant JN, Katz SI, Dolloff NG, Smith CD, Abdulghani J, Allen JE, Dicker DT, Hong B, Navaraj A, El-Deiry WS.
Wang W, et al. Among authors: hong b.
Cancer Biol Ther. 2011 Aug 1;12(3):229-38. doi: 10.4161/cbt.12.3.17033. Epub 2011 Aug 1.
Cancer Biol Ther. 2011.
PMID: 21725212
Free article.